| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 10/11/2005 | US6953690 Compositions and methods for helper-free production of recombinant adeno-associated viruses |
| 10/11/2005 | US6953581 Porcine circovirus and parvovirus vaccine |
| 10/06/2005 | WO2005093070A1 Recombinant herpesvirus and utilization of the same |
| 10/06/2005 | WO2005093049A1 Cellular and viral inactivation |
| 10/06/2005 | WO2005092069A2 Chimeric infectious dna clones, chimeric porcine circoviruses and uses thereof |
| 10/06/2005 | WO2005091753A2 Flexible vaccine assembly and vaccine delivery platform |
| 10/06/2005 | WO2005062820A9 Multi plasmid system for the production of influenza virus |
| 10/06/2005 | WO2005051330A3 METHOD FOR TREATING HUMAN TUMOR CELLS WITH A NEWCASTLE DISEASE VIRUS STRAIN HAVING A p53 INDEPENDENT ONCOLYTIC EFFECT |
| 10/06/2005 | WO2005007877A3 Regulatable promoters for synthesis of small hairpin rna |
| 10/06/2005 | WO2004078912A8 Chicken rna polymerase i promoter and the use thereof |
| 10/06/2005 | US20050221493 Recombinant virus production for the manufacturing of vaccines |
| 10/06/2005 | US20050221492 Means and methods for nucleic acid delivery vehicle design and nucleic acid transfer |
| 10/06/2005 | US20050221491 In vivo selection method for determining inhibitory RNA molecules |
| 10/06/2005 | US20050221490 DNA virus microRNA and methods for inhibiting same |
| 10/06/2005 | US20050221489 Recombinant negative strand virus rna expression systems and vaccines |
| 10/06/2005 | US20050221464 Method for culturing hcv virus in vitro |
| 10/06/2005 | US20050221434 Receptor of the EDb-fibronectin domains |
| 10/06/2005 | US20050221293 Isolated nucleic acid molecule comprising the sequence of a DNA virus microRNA; Epstein barr virus; inhibiting microRNP activity in a cell |
| 10/06/2005 | US20050221289 Altering viral tropism |
| 10/06/2005 | US20050220813 Non-spreading pestivirus |
| 10/06/2005 | US20050220767 Production of recombinant respiratory syncytial viruses expressing immune modulatory molecules |
| 10/06/2005 | US20050220766 Viral vectors and methods for producing and using the same |
| 10/06/2005 | CA2557800A1 Cellular and viral inactivation |
| 10/05/2005 | EP1581257A1 A method of treating a malignancy in a subject via direct picornaviral-mediated oncolysis |
| 10/05/2005 | EP1507851B1 Method for assembling sub units into capsoides |
| 10/05/2005 | EP1305038B1 Bacteriophage having multiple host range |
| 10/05/2005 | CN1678758A Large circular sense molecule array |
| 10/05/2005 | CN1678749A Non-human herpesviruses as vectors |
| 10/05/2005 | CN1678345A Multi plasmid system for the production of influenza virus |
| 10/05/2005 | CN1221665C Use of negative regulation elements for nerve-specific expression of transgenes |
| 10/04/2005 | US6951758 Helper virus-free AAV production |
| 10/04/2005 | US6951755 Vectors and methods for gene transfer |
| 10/04/2005 | US6951754 Expression vector for use as transformation and gene expression tool in genetic engineering |
| 10/04/2005 | US6951753 Helper-free stocks of recombinant adeno-associated virus vectors |
| 10/04/2005 | US6951752 Method for large scale production of virus antigen |
| 10/04/2005 | US6951650 Antigenic class of avian reoviruses |
| 10/04/2005 | CA2105304C Inhibitors of human neutrophil elastase and human cathepsin g |
| 09/29/2005 | WO2005090584A2 Influenza vaccine based on fowl plague viruses |
| 09/29/2005 | WO2005090390A1 Novel assay for the separation and quantification of hemagglutinin antigens |
| 09/29/2005 | WO2005089795A2 Infectious bursal disease virus antigenic isolates and vaccines |
| 09/29/2005 | WO2005089712A1 Lyophilization method to improve excipient crystallization |
| 09/29/2005 | WO2005063801A3 Method for decreasing the contact between hepta-repeat region s of the corona-virus spike proteins and use thereof |
| 09/29/2005 | WO2005062709A3 Integrated viral complexes, methods of production thereof, vaccines containing same and methods of use thereof |
| 09/29/2005 | WO2005056807A3 Bovine adeno-associated viral (baav) vector and uses thereof |
| 09/29/2005 | WO2004108939A8 Bav packaging regions and e1 transcriptional control regions |
| 09/29/2005 | WO2004014314A3 Methods and compositions concerning poxviruses and cancer |
| 09/29/2005 | US20050214923 Recombinant viral vector comprising antitumor agents for use in targeted tissue therapy; gene therapy |
| 09/29/2005 | US20050214859 Hepatocyte growth factor (HGF) receptor complex for identifying modulator for prevention and treatment of cell proliferative disorders |
| 09/29/2005 | US20050214324 Culturing avian cells permissive for productive replication of the virus in a serum free medium containing a growth factor or an attachment factor, infecting of the cells with the virus, and cultivating in serum free media until progeny virus is produced |
| 09/29/2005 | US20050214323 Modified vaccinia ankara virus variant and cultivation method |
| 09/29/2005 | US20050214321 Recombinant icosahedral virus like particle production in pseudomonads |
| 09/29/2005 | US20050214318 Immunogenic composition and method of developing a vaccine based on fusion protein |
| 09/29/2005 | US20050214317 A binding site of the cystosolic protein cyclophilin A on human immunodeficiency virus capsid protein, which may be expressed by a recombinant viral, bacterial or yeast carrier; may be treated with neuraminidase or trypsin to remove sialic acid; immune stimulant such as teichoic acid or zymosan |
| 09/29/2005 | US20050214316 Generating and sequencing an infectious bursal disease virus cDNA from sample suspected of having a strain of IBDV, aligning the sequence with one or more IBDV sequences, and comparing relatedness of aligned IBDV sequences; selecting a vaccine for chickens, ducks, geese, pheasants, quail and turkeys. |
| 09/29/2005 | US20050214256 Expression cassette generated from these sequences; generating an immune response in a subject |
| 09/29/2005 | CA2560185A1 Novel assay for the separation and quantification of hemagglutinin antigens |
| 09/29/2005 | CA2557844A1 Infectious bursal disease virus antigenic isolates and vaccines |
| 09/29/2005 | CA2554018A1 Lyophilization method to improve excipient crystallization |
| 09/28/2005 | EP1578965A2 Sorbent and method for the separation of plasmid dna |
| 09/28/2005 | EP1578960A1 Magnetism based rapid cell separation |
| 09/28/2005 | EP1578959A1 Immunizing fish against viral infection |
| 09/28/2005 | EP1578956A2 Highly permissive cell lines for hepatitis c virus replication |
| 09/28/2005 | EP1578919A2 Endogenous retrovirus up-regulated in prostate cancer |
| 09/28/2005 | EP1578396A2 Methods and compositions concerning poxviruses and cancer |
| 09/28/2005 | EP1578374A2 Escape mutants of newcastle disease virus as marker vaccines |
| 09/28/2005 | EP0991763B1 Modified adenoviral fiber and target adenoviruses |
| 09/28/2005 | CN1673362A Process for preparing human papillomavirus through culturing Hela cell |
| 09/22/2005 | WO2005087262A1 Chicken anemia virus vaccine from cell line |
| 09/22/2005 | US20050208661 Viral plasmid for use as tool in heterologous gene transfer; gene therapy |
| 09/22/2005 | US20050208483 Kits for detecting anti-sirs antibodies |
| 09/22/2005 | US20050208074 Anticancer agents; gene therapy; trimers; host cells; genomes |
| 09/22/2005 | US20050208071 Expresses all structural proteins of a pestivirus (e.g., BVDV) except for a functional C protein; coding sequences for a signal sequence within the C protein essential for post translational processing are retained or replaced by a sequence for analogous signal sequences from another pestiviral species |
| 09/22/2005 | US20050208066 Fusion proteins; severe acute respiratory syndrome coronavirus; double-stranded RNA; drug screening |
| 09/22/2005 | US20050208064 Peptide capable of inducing immune response to human gastric cancer and agent for preventing or treating human gastric cancer, containing the peptide |
| 09/22/2005 | US20050208024 Treating cancer in humans; obtain human, administer antitumor agent, evaluate tumor response to antitumor agents |
| 09/22/2005 | CA2558736A1 Chicken anemia virus vaccine from cell line |
| 09/21/2005 | EP1576877A1 Preparation of recombinant rotavirus proteins in milk of transgenic non-human mammals |
| 09/21/2005 | EP1576143A2 Virus-like particles, methods of preparation, and immonogenic compositions |
| 09/21/2005 | EP1576090A2 Metapneumovirus strains and their use in vaccine formulations and as vector for expression of antigenic sequences |
| 09/21/2005 | EP1575979A2 West nile virus vaccine |
| 09/21/2005 | EP1575611A2 Modified vaccinia ankara expressing p53 in cancer immunotherapy |
| 09/21/2005 | EP1263936B1 Altered strain of the modified vaccinia virus ankara (mva) |
| 09/21/2005 | CN1671851A Flavivirus vaccine delivery system |
| 09/20/2005 | US6946296 Methods and compositions for polypeptide engineering |
| 09/20/2005 | US6946136 Temperature-sensitive and cold-adapted human parainfluenza virus type 2 (HPIV-2) and vaccines based on such virus |
| 09/20/2005 | US6946075 Using a cross-flow filter; chromatography |
| 09/20/2005 | CA2189882C Papillomavirus vaccines |
| 09/15/2005 | WO2005085445A1 Recombinant varicella-zoster virus |
| 09/15/2005 | WO2005084427A1 Preparation of recombinant rotavirus proteins in milk of transgenic non human mammals |
| 09/15/2005 | WO2005047458A3 Modified recombinant vaccina viruses and other microorganisms, uses thereof |
| 09/15/2005 | WO2005023837A3 Ebola peptides and immunogenic compositions containing same |
| 09/15/2005 | US20050202553 Animal cells and processes for the replication of influenza viruses |
| 09/15/2005 | US20050202077 Targeted delivery of RNA interference molecules |
| 09/15/2005 | US20050202045 Recombinant avian herpesvirus useful in vaccine production |
| 09/15/2005 | US20050201983 Capsid and capsid-expressing genome modified to display heterologous peptide(s) to allow nuclear or subcellular targeting by delivering a peptide into the cell nucleus; easy construction of libraries using site-specific recombination in vitro; peptide/protein fusion with capsid protein vp39 (AcMNPV) |
| 09/15/2005 | US20050201934 Binding peptides for carcinoembryonic antigen (CEA) |
| 09/15/2005 | CA2558586A1 Recombinant varicella-zoster virus |
| 09/15/2005 | CA2557953A1 Preparation of recombinant rotavirus proteins in milk of transgenic non human mammals |
| 09/15/2005 | CA2557819A1 Magnetic device for isolation of cells and biomolecules in a microfluidic environment |
| 09/14/2005 | EP1572985A1 Production of alvac on avian embryonic stem cells |